glp 1 drugs and pancreatitis Updates in Medicine | GLP-1s may raise risk early—but over time, protective effects balance the scale, resulting in no increase in overall 1-year risk Why Does GLP-1 Cause Pancreatitis?
Description
Wegovy Vision Loss Lawsuit Overview According to legal documents, patients allege that Novo Nordisk, the manufacturer of Wegovy, knew the drug might increase a persons risk of developing serious eye injuries such as nonarteritic anterior ischemic optic neuropathy (NAION) and failed to adequately warn consumers

Fluorescent GLP1R/GIPR dual agonist probes reveal cell targets in the pancreas and brain

6 , 859869 (2018) J.B

They require monitoring from a licensed medical professional
Cardiovascular-kidney-metabolic health: a presidential advisory from the American Heart Association

GLP-1 Therapeutics and Market Context Evolution of the GLP-1 Drug Class GLP-1 receptor agonists mimic the natural GLP-1 hormone
